subject area of
- 5-Azacytidine upregulates melatonin MT1 receptor expression in rat C6 glioma cells: oncostatic implications Journal Articles
- A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia Journal Articles
- Application of Octanohydroxamic Acid for Salting out Liquid–Liquid Extraction of Materials for Energy Storage in Supercapacitors Journal Articles
- BCL11A represses HBG transcription in K562 cells Journal Articles
- Clinically relevant concentrations of valproic acid modulate melatonin MT1 receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells Journal Articles
- Elimination of 4-n-Butoxyphenylacethydroxamic Acid (Bufexamac) in Man Journal Articles
- Epigenetic induction of melatonin MT 1 receptors by valproate: Neurotherapeutic implications Journal Articles
- Estimation of 4-Butoxyphenylacetohydroxamic Acid Utilizing the Lossen Rearrangement Journal Articles
- HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation Journal Articles
- Histone Deacetylation Is Involved in the Transcriptional Repression of hTERT in Normal Human Cells Journal Articles
- Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer Journal Articles
- Inhibition of Helicobacter pylori by acetohydroxamic acid Journal Articles
- Inhibition of leucine aminopeptidase by amino acid hydroxamates. Journal Articles
- Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid. Journal Articles
- Metalloprotease domain latency protects ADAMTS13 against broad-spectrum inhibitors of metalloproteases while maintaining activity toward VWF Journal Articles
- Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas Journal Articles
- Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer Journal Articles
- Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) Journal Articles
- Phase II Study of Marimastat (BB-2516) in Malignant Melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group Journal Articles
- Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours Journal Articles
- Phase II trial of vorinostat in advanced melanoma Journal Articles
- Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases Journal Articles
- Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth Journal Articles
- Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines Journal Articles
- Synergistic binding of ligands to angiotensin-converting enzyme. Journal Articles